These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 33661066

  • 1. Peripheral Blood Transcriptome in Patients with Sarcoidosis-Associated Uveitis.
    Gonzales JA, Takhar JS, Joye A, Acharya NR, Chen C, Hinterwirth A, Doan T.
    Ocul Immunol Inflamm; 2022 Jul; 30(5):1074-1077. PubMed ID: 33661066
    [Abstract] [Full Text] [Related]

  • 2. Multicenter, retrospective, observational study for the Treatment Pattern of systemic corticoSTERoids for relapse of non-infectious uveitis accompanying Vogt-Koyanagi-Harada disease or sarcoidosis.
    Namba K, Takase H, Usui Y, Nitta F, Maruyama K, Kusuhara S, Takeuchi M, Azumi A, Yanai R, Kaneko Y, Hasegawa E, Nakai K, Tsuruga H, Morita K, Kaburaki T.
    Jpn J Ophthalmol; 2022 Mar; 66(2):130-141. PubMed ID: 35044561
    [Abstract] [Full Text] [Related]

  • 3. Association of the C2-CFB locus with non-infectious uveitis, specifically predisposed to Vogt-Koyanagi-Harada disease.
    Yang M, Fan JJ, Wang J, Zhao Y, Teng Y, Liu P.
    Immunol Res; 2016 Apr; 64(2):610-8. PubMed ID: 26671509
    [Abstract] [Full Text] [Related]

  • 4. Decreased interleukin(IL)-35 Expression is Associated with Active Intraocular Inflammation in Vogt-Koyanagi-Harada (VKH) Disease.
    Hu J, Qin Y, Yi S, Wang C, Yang J, Yang L, Wang L, Kijlstra A, Yang P, Li H.
    Ocul Immunol Inflamm; 2019 Apr; 27(4):595-601. PubMed ID: 29498905
    [Abstract] [Full Text] [Related]

  • 5. [Management of uveomeningitis in internal medicine: Proposal for a diagnostic work-up].
    Abad S, Terrada C, Trad S, Sène D, Bielefeld P, Saadoun D, Sève P.
    Rev Med Interne; 2016 Jan; 37(1):25-34. PubMed ID: 26541836
    [Abstract] [Full Text] [Related]

  • 6. Retinal vessel oxygen saturation is affected in uveitis associated with Vogt-Koyanagi-Harada disease.
    Abu El-Asrar AM, AlBloushi AF, Gikandi PW, Hardarson SH, Stefánsson E.
    Br J Ophthalmol; 2019 Dec; 103(12):1695-1699. PubMed ID: 30798260
    [Abstract] [Full Text] [Related]

  • 7. Changing patterns of intraocular inflammatory disease in Japan.
    Wakabayashi T, Morimura Y, Miyamoto Y, Okada AA.
    Ocul Immunol Inflamm; 2003 Dec; 11(4):277-86. PubMed ID: 14704899
    [Abstract] [Full Text] [Related]

  • 8. The CC chemokines CCL8, CCL13 and CCL20 are local inflammatory biomarkers of HLA-B27-associated uveitis.
    Abu El-Asrar AM, Berghmans N, Al-Obeidan SA, Gikandi PW, Opdenakker G, Van Damme J, Struyf S.
    Acta Ophthalmol; 2019 Feb; 97(1):e122-e128. PubMed ID: 30242977
    [Abstract] [Full Text] [Related]

  • 9. [Vitiligo revealing Vogt -Koyanagi-Harada disease].
    Amraoui ME, Zemmez Y, Bouhamidi A, Frikh R, Hjira N, Boui M.
    Pan Afr Med J; 2017 Feb; 27():220. PubMed ID: 28979622
    [Abstract] [Full Text] [Related]

  • 10. Decreased expression of A20 is associated with ocular Behcet's disease (BD) but not with Vogt-Koyanagi-Harada (VKH) disease.
    He Y, Wang C, Su G, Deng B, Ye Z, Huang Y, Yuan G, Aize K, Li H, Yang P.
    Br J Ophthalmol; 2018 Aug; 102(8):1167-1172. PubMed ID: 29699987
    [Abstract] [Full Text] [Related]

  • 11. Decreased microRNA-155 expression in ocular Behcet's disease but not in Vogt Koyanagi Harada syndrome.
    Zhou Q, Xiao X, Wang C, Zhang X, Li F, Zhou Y, Kijlstra A, Yang P.
    Invest Ophthalmol Vis Sci; 2012 Aug 17; 53(9):5665-74. PubMed ID: 22815348
    [Abstract] [Full Text] [Related]

  • 12. Frequency of distinguishing clinical features in Vogt-Koyanagi-Harada disease.
    Rao NA, Gupta A, Dustin L, Chee SP, Okada AA, Khairallah M, Bodaghi B, Lehoang P, Accorinti M, Mochizuki M, Prabriputaloong T, Read RW.
    Ophthalmology; 2010 Mar 17; 117(3):591-9, 599.e1. PubMed ID: 20036008
    [Abstract] [Full Text] [Related]

  • 13. Use of systemic corticosteroids in patients newly registered at a claims database with a diagnosis of non-infectious uveitis: results from a real-world claims database analysis.
    Umazume A, Ohguro N, Okada AA, Namba K, Sonoda KH, Tsuruga H, Morita K, Goto H.
    Jpn J Ophthalmol; 2022 Jul 17; 66(4):394-404. PubMed ID: 35670922
    [Abstract] [Full Text] [Related]

  • 14. Outcomes of initial-onset acute uveitis associated with Vogt-Koyanagi-Harada disease occurred during pregnancy.
    Alromaih AZ, Almater AI, Albloushi AF, Alkheraiji NF, Abu El-Asrar AM.
    Int Ophthalmol; 2023 Jan 17; 43(1):185-195. PubMed ID: 35945413
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Diminished frequency and function of CD4+CD25high regulatory T cells associated with active uveitis in Vogt-Koyanagi-Harada syndrome.
    Chen L, Yang P, Zhou H, He H, Ren X, Chi W, Wang L, Kijlstra A.
    Invest Ophthalmol Vis Sci; 2008 Aug 17; 49(8):3475-82. PubMed ID: 18421089
    [Abstract] [Full Text] [Related]

  • 20. Immunogenetics and uveitis.
    Yabuki K, Inoko H, Ohno S.
    Dev Ophthalmol; 1999 Aug 17; 31():77-91. PubMed ID: 10641201
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.